tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

VivoSim Labs Avoids Nasdaq Delisting with Compliance Plan

Story Highlights
  • VivoSim Labs faced Nasdaq compliance issues over stockholders’ equity and bid price.
  • By April 2025, the company met compliance, avoiding delisting and entering monitoring.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
VivoSim Labs Avoids Nasdaq Delisting with Compliance Plan

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

VivoSim Labs ( (VIVS) ) just unveiled an announcement.

VivoSim Labs, Inc. faced compliance issues with Nasdaq listing requirements, specifically failing to maintain a minimum stockholders’ equity of $2,500,000 and a minimum bid price of $1.00 per share. After receiving notices from Nasdaq in January and February 2025, the company requested a hearing and presented a compliance plan. By April 30, 2025, VivoSim Labs successfully demonstrated compliance with the necessary rules, avoiding delisting and entering a one-year mandatory monitoring period by Nasdaq.

More about VivoSim Labs

Average Trading Volume: 836,898

Technical Sentiment Signal: Sell

Current Market Cap: $3.4M

Learn more about VIVS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1